Cargando…

Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data

In lung cancer, DNA content abnormalities have been described as a heterogeneous spectrum of impaired tumour cell DNA histogram patterns. They are merged into the common term of aneuploidy and probably reflect a high genotypic instability. In non-small-cell lung cancer, the negative effect of aneupl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choma, D, Daurès, J-P, Quantin, X, Pujol, J L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363907/ https://www.ncbi.nlm.nih.gov/pubmed/11437396 http://dx.doi.org/10.1054/bjoc.2001.1892

Ejemplares similares

Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent
por: Pujol, J-L, et al.
Publicado: (2000)

Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis
por: Boher, J-M, et al.
Publicado: (1999)

Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors
por: Jacot, W, et al.
Publicado: (2001)

Smoking and apolipoprotein levels: A meta-analysis of published data
por: Kauss, Alba Romero, et al.
Publicado: (2022)

Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer
por: Pujol, P, et al.
Publicado: (1999)

An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer
por: Pujol, Jean-Louis, et al.
Publicado: (2019)

Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer
por: Keum, J S, et al.
Publicado: (1999)

X chromosome aneuploidies and schizophrenia: association analysis and phenotypic characterization
por: Kushima, Itaru, et al.
Publicado: (2022)

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature
por: Sculier, J P, et al.
Publicado: (2001)

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients
por: Pujol, J-L, et al.
Publicado: (2004)

Gefitinib versus Docetaxel in Treated Non-small-cell Lung Cancer: A Meta-analysis
por: Wang, Bing, et al.
Publicado: (2017)

Preimplantation genetic testing for aneuploidy: A review of published blastocyst reanalysis concordance data
por: Marin, Diego, et al.
Publicado: (2020)

A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index
por: Colinet, B, et al.
Publicado: (2005)

Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers.
por: Pujol, J. L., et al.
Publicado: (1996)

Experiments and Analyses of Anonymization Mechanisms for Trajectory Data Publishing
por: Sun, She, et al.
Publicado: (2022)

Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer
por: Alessi, Joao V, et al.
Publicado: (2023)

Predictive value of expression of p16(INK4A), retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers
por: Hommura, F, et al.
Publicado: (1999)

Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancer
por: Jacot, W, et al.
Publicado: (2004)

Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study
por: Douillard, J Y, et al.
Publicado: (2001)

Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer
por: Schneider, P M, et al.
Publicado: (2000)

Frontline gefitinib in advanced non-small cell lung cancer: Meta-analysis of published randomized trials
por: Ibrahim, Ezzeldin M.
Publicado: (2010)

Mutational burden and chromosomal aneuploidy synergistically predict survival from radiotherapy in non-small cell lung cancer
por: Jia, Qingzhu, et al.
Publicado: (2021)

Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer
por: Sørensen, J B, et al.
Publicado: (1999)

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines
por: Moorsel, C J A van, et al.
Publicado: (1999)

Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL -2-mediated neovascularization
por: Boldrini, L, et al.
Publicado: (2000)

Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features
por: Geradts, J, et al.
Publicado: (2000)

Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland
por: Rusin, M, et al.
Publicado: (1999)

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma
por: Koukourakis, M I, et al.
Publicado: (1999)

Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer
por: Beretta, G D, et al.
Publicado: (2000)

Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis
por: Sawada, M, et al.
Publicado: (1999)

Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer
por: Earle, C C, et al.
Publicado: (1999)

Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer
por: Nakamura, Masatoshi, et al.
Publicado: (2023)

Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas
por: Fontanini, G, et al.
Publicado: (1999)

Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival
por: Volm, M, et al.
Publicado: (2000)

Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell lines
por: Kroep, J R, et al.
Publicado: (2000)

Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer
por: Borner, M M, et al.
Publicado: (1999)

The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression
por: Vonlanthen, S, et al.
Publicado: (2001)

The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer
por: Kajita, T, et al.
Publicado: (2001)

Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen
por: Forsberg, G, et al.
Publicado: (2001)

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer
por: Shou, Y, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_9ijoiri6dvg8o2f5uumjnfbgul